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MEGF10 is predominantly expressed in the brain and known to function as a phagocytic receptor.
Here, we provide evidence that MEGF10 is involved in the uptake of amyloid-b peptide (Ab42) in
the brain. Overexpression of MEGF10 dramatically increased Ab42 uptake in Hela cells. Knockdown
of endogenous MEGF10 expression signiﬁcantly decreased Ab42 uptake in N2A neuroblastoma cells.
MEGF10-mediated Ab uptake is mostly dependent on lipid raft endocytosis pathway. Furthermore,
site-directed mutagenesis revealed that the conserved cytoplasmic NPxY and YxxØmotifs are crucial
for MEGF10-mediated uptake of Ab42 peptide. Thus, the identiﬁcation of the MEGF10 as a functional
receptor that mediates the uptake of amyloid-b peptide will help elucidate the molecular mecha-
nisms of amlyoid-b clearance in Alzheimer’s disease.
Structured summary:
MINT-7993537: ctxB (uniprotkb:P01556) and Abeta (uniprotkb:P05067) colocalize (MI:0403) by ﬂuores-
cence microscopy (MI:0416)
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Alzheimer’s disease (AD) is characterized by extracellular accu-
mulation of senile plaques, the major component of which is the
amyloid-b peptide (Ab), and the presence of neuroﬁbrillary tangles
[1]. The pathogenic 40- and 42-amino acid forms of amyloid-b are
produced by proteolytic processing of the amyloid protein precur-
sor (APP) by b- and c-secretases [2–4]. In particular, Ab42 is the
more amyloidogenic form and has a higher tendency to form ﬁbrils
[5]. Accumulation of Ab in the brain is determined by increased Ab
production or insufﬁcient Ab clearance and induces the formation
of toxic ﬁbrils in neuritic plaques as well as toxic soluble oligomers
[6,7]. Although the molecular mechanism of Ab production has
been investigated extensively, relatively little is known about the
mechanism of endocytic or phagocytic Ab clearance.
Multiple EGF-like domains 10 (MEGF10) is a type I transmem-
brane protein that consists of 17 EGF-like domains in extracellular
region and is known as a mammalian ortholog of nematode CED-1
[8–10]. MEGF10, in co-operation with the ATP binding cassette
transporter ABCA1, is known to be involved in cell corpse clearancechemical Societies. Published by E
y.[9]. MEGF10 interacts with the AP-2 complex by directly binding to
AP50, which strongly suggests that MEGF10 is taken into endo-
somes through clathrin-mediated endocytosis and then trans-
ported to lysosomes [11]. Although the localization of MEGF10
within the brain is still not completely clear, MEGF10 is predomi-
nantly expressed in the brain [8,11,12]. These observations suggest
that MEGF10 may be involved in the uptake of Ab in the brain.
Accordingly, the potential role of MEGF10 in Ab42 uptake is ad-
dressed and supported by the evidence reported herein.
2. Materials and methods
2.1. Animals and reagents
A double transgenic mouse model of Alzheimer’s disease (AD)
was used for the evaluation of MEGF10. Amyloid precursor pro-
tein/presenilin1 (APP/PS1) double transgenic and non-transgenic
mice were generated frommatings between single transgenic mice
expressing human mutant APP [13] and mutant PS1 [14]. The sin-
gle APP and PS1 transgenic mice were originally obtained from
Taconic and Jackson Laboratory, respectively. All procedures were
in accordance with an animal protocol approved by the Kyungpook
National University Institutional Animal Care and Use Committee
(IACUC). Monoclonal anti-FLAG M2 antibody was obtained fromlsevier B.V. All rights reserved.
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Biosciences. Alexa Fluor 594-conjugated Cholera toxin subunit B
and G418 were acquired from Invitrogen. MEGF10 siRNA and
non-targeting siRNA were purchased from Dharmacon. Fluorescein
isothiocyanate (FITC)-conjugated human amyloid-b (1–42) peptide
(FITC-Ab42) was obtained from rPeptide and prepared in accor-
dance with the manufacturer’s instructions.
2.2. Plasmids
The complete human MEGF10 cDNA clone (Genbank accession
No.: NM_032446) was purchased from Origene and subcloned into
pCDNA3.1(+) vector (Invitrogen) in conjunction with a FLAG-tag at
the C-terminus of MEGF10. Expression vectors encoding mutant
MEGF10 (MEGF10-APxA and MEGF10-AxxA) was generated by
site-directed mutagenesis using Quikchange (Stratagene), in accor-
dance with the manufacturer’s instructions. All plasmids were con-
ﬁrmed by DNA sequencing.
2.3. Cell culture and transfection
N2A (mouse neuroblastoma cells) and HeLa cells were main-
tained in Dulbecco’s Modiﬁed Eagle Medium (DMEM) supple-
mented with 10% (v/v) heat-inactivated fetal bovine serum (FBS)
and appropriate antibiotics (Invitrogen). HeLa cells were transfec-
ted with MEGF10 expression vector using Lipofectamine 2000, in
accordance with the manufacturer’s instructions (Invitrogen). For
stable transfection, HeLa cells were selected in G418 (600 lg/ml).
Individual G418-resistant colonies were isolated after 2 weeks of
culture. The ﬁnal clones were designated as HeLa/MEGF10, and
negative control clones were selected randomly from transfection
with empty vector (HeLa/mock). The cells were analyzed for
expression of MEGF10 by Western blotting using a monoclonal
anti-FLAG antibody.
2.4. Production of polyclonal anti-MEGF10 antibody
Production of polyclonal anti-human MEGF10 antibody was
performed by Peptron (Seoul, Korea). Brieﬂy, peptide sequence
CTAYRHGEKTMYRRKS-NH2 (78–92) was synthesized and coupled
to the immunogenic carrier protein keyhole limpet hemocyanin
(KLH) via an additional cysteine in the synthetic peptide by the
N-c-maleimidobutyryloxylsuccinimide (GMBS) conjugation meth-
od. New Zealand white rabbits (typically 10 weeks old, mostly
female) were immunized with 400 lg of the peptide-KLH conju-
gate by subcutaneous injections at 3-week intervals. The ﬁnal
anti-sera were further puriﬁed by Protein A afﬁnity chromatogra-
phy (Amersham Pharmacia), in accordance with the manufac-
turer’s protocols. The speciﬁcity of polyclonal anti-MEGF10
antibody was examined by Western blotting and immunoﬂuores-
cence staining in HeLa/MEGF10 cells.
2.5. Quantitative real-time polymerase chain reaction (PCR)
Total RNA were isolated from murine cell lines using Trizol
reagent, in accordance with the manufacturer’s instructions. Re-
verse transcription was performed with M-MLV reverse transcrip-
tase (Promega) using 2 lg of total RNA for 50 min at 42 C,
followed by 3 min at 95 C. For real-time PCR, cDNA produced
by reverse transcription was diluted 2.5-fold, and SYBR green
master mix (Roche Applied Science) was used to amplify MEGF10
or a b-actin control. Real-time PCR ampliﬁcation was carried out
in a LightCycler 480 (Roche Applied Science) using the following
primers: mouse MEGF10 forward, 50-ACT ACA CAA GCT GCA CCG
ACA TC-30; mouse MEGF10 reverse, 50-AAC CAG AAG GGC AAG
AGC ACT-30; b-actin forward, 50-TCA CCC ACA CTG TGC CCA TCTACG A-30; and b-actin reverse, 50-GGA TGC CAC AGG ATT CCA
TAC CCA-30. The comparative cycle threshold (CT) method was
used as previously described to analyze the data by generating
relative values of the amount of target cDNA [15].
2.6. MEGF10 knockdown
The following oligonucleotides for MEGF10 siRNA were pur-
chased from Dharmacon RNA technologies: sense sequence, 50-CU-
GAACAGCUUAAGCCGAAUU-30 and anti-sense sequence, 50-
UUCGGCUUAAGCUGUUCAGUU-30. siGENOME non-targeting siRNA
were used as control siRNA. N2A cells were then transfected with
200 nM of siRNA duplex using HiPerFect Transfection Reagent
(Qiagen) according to the manufacturer’s instructions. Twenty four
hours following transfection, the cells were recovered in complete
medium for 24 h, and the effect on MEGF10 expression was exam-
ined by Western blotting.
2.7. Internalization of amyloid-b
FITC-Ab42 uptake analysis was performed via confocal micro-
scope as previously described [16], with slight modiﬁcations.
Brieﬂy, 6  104 cells were seeded in 4-well chamber slides, and
the next day, cell preparations were incubated with 1 lg/ml
FITC-Ab42 for 1 h at 37 C. The cells were then washed with HBSS
and ﬁxed for 10 min with 4% paraformaldehyde (in PBS). Following
staining with 406-diamidino-2-phenylindole (DAPI), internalized
FITC-Ab42 appeared as punctuate ﬂuorescent vesicles, which were
quantiﬁed under a confocal microscope. All the images were cap-
tured in sequential scanning mode using a Zeiss LSM-510 Meta
confocal microscope and a Zeiss Plan Apochromat 63 oil immer-
sion lens (NA 1.4). In knockdown experiments, N2A cells were
transfected with MEGF10 siRNA or non-targeting control siRNA
and then incubated with 1 lg/ml of FITC-Ab42 at 48 h post-trans-
fection. In some experiments, N2A cells were pretreated with
5 mM methyl-b-cyclodextrin for 30 min prior to addition of FITC-
Ab42. For quantiﬁcation of internalized FITC-Ab42, images were
captured in sequential scanning mode using a Zeiss LSM-510 Meta
confocal microscope. The pinhole was set such that each optical
section was 1 lm thick. All the images were acquired at a
1024  1024 pixel resolution with 4096 grey levels per pixel. To
minimize any background auto-ﬂuorescence and non-speciﬁc
binding of FITC-Ab42, pixel intensity was only measured in the
brighter cellular regions. The region of interest (ROI) within each
cell was traced using the Zeiss LSM-5 Exciter software. At least
30 cells were analyzed per image for samples with more or less
similar areas (lm  lm) of quantiﬁcation and the total ﬂuores-
cence intensity was quantiﬁed for the selected regions (ROI) of
the images from at least three independent experiments. The mean
pixel intensity was calculated for each channel in the ROI.
2.8. Immunoﬂuorescence and confocal microscopy
To analyze the colocalization between internalized FITC-Ab42
and EEA1 or cholera toxin subunit B (CTxB), N2A cells are seeded
in 4-well chamber slides, and the next day, cell preparations were
incubated with 1 lg/ml of FITC-Ab42 for 1 h. The cells were
washed with PBS three times and ﬁxed with 4% paraformaldehyde
(in PBS) for 10 min at room temperature. After washes with PBS,
the cells were permeabilized with 0.2% Triton X-100. Non-speciﬁc
binding was minimized by incubating the cells in PBS containing
5% BSA (bovine serum albumin) for 40 min at room temperature.
The cells were then incubated with anti-EEA1 antibody or
594-conjugated Cholera toxin subunit B for 90 min at room
temperature and rinsed thoroughly with PBS, followed by incuba-
tion with secondary antibodies (Molecular Probes) for 1 h at room
Fig. 1. Overexpression of MEGF10 mediates the uptake of Ab42 in HeLa cells. (A) The expression of MEGF10-FLAG was analyzed by Western blotting using a monoclonal anti-
FLAG antibody. The arrowhead indicates MEGF10 protein. Lane 1, Hela/mock cells; Lane 2, Hela/MEGF10 cells. (B) HeLa/MEGF10 and HeLa/mock cells were incubated with
1 lg/ml FITC-Ab42 for 1 h at 37 C. Internalization of FITC-Ab42 (green) was analyzed by capturing sequential scanning images using a confocal microscope. Confocal
microscopic z-series images show the presence of FITC-Ab42 inside the cytoplasm of HeLa/MEGF10 cells. Scale bar, 20 lm. (C) The intensity of internalized FITC-Ab42 in
HeLa/MEGF10 and HeLa/mock cells was quantiﬁed from images captured in sequential scanning mode using a confocal microscope. The results are expressed as the
mean ± S.D. from three independent experiments. Statistical analysis of signiﬁcance by t-test: *P < 0.01.
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stained with DAPI for 3 min, washed three times with PBS for
5 min each, and treated with a solution of SlowFade (Molecular
Probes). The slides were viewed with a Zeiss light microscope
using Axioplan2 imaging. Images were captured and analyzed in
sequential scanning mode using a Zeiss LSM-510 Meta confocal
microscope.
For immunoﬂuorescence staining in wild-type and AD animals,
the mice were anesthetized with 2.5% avertin in PBS and immedi-
ately cardiac perfused with 4% paraformaldehyde in PBS. After per-
fusion, brains were excised, postﬁxed overnight at 4 C, and
incubated in 30% sucrose at 4 C until equilibrated. Sequential
14 lm coronal sections were incubated with anti-MEGF10 anti-
body overnight at 4 C. After several rinses with PBS, the sections
were then incubated with Alexa Fluor 488-conjugated secondary
antibody for 1 h at RT. The sections were analyzed with a laserFig. 2. Knockdown of MEGF10 inhibits the uptake of Ab42 in neuroblastoma cells. (A) G
real-time PCR. A representative result of two independent experiments is shown. C6, rat
cells were transfected with control (PBS), 200 nMMEGF10 siRNA, and 200 nM control siR
by immunoﬂuorescence staining. Scale bar, 50 lm. A representative result of three indepe
were incubated with 1 lg/ml FITC-conjugated Ab42 for 1 h at 37 C. Internalization of
confocal microscope. Confocal microscopic z-series images show the presence of FITC
internalized FITC-Ab42 in MEGF10 siRNA- or control siRNA-treated N2A cells was quantiﬁ
The results are expressed as the mean ± S.D. from three independent experiments. Statiscanning confocal microscope equipped with Fluoview FV1000
imaging software (Olympus FV1000, Japan).2.9. Statistical analysis
The statistical signiﬁcance was assessed using the t-test and a
P < 0.05 was considered to be statistically signiﬁcant.3. Results and discussion
3.1. MEGF10 contributes to uptake of Ab42 peptide
Based on the role of MEGF10 as a phagocytic receptor [9], the
restricted expression of MEGF10 to brain tissues prompted us to
investigate its role in uptake of amyloid-b peptide which is knownene transcript of MEGF10 was analyzed in cell lines of brain origin by quantitative
glioma cells; BV2, mouse microglial cells; N2A, mouse neuroblastoma cells. (B) N2A
NA. At 48 h post-transfection, MEGF10 expression at the protein levels was analyzed
ndent experiments is shown. (C) MEGF10 siRNA- or control siRNA-treated N2A cells
FITC-Ab42 (green) was analyzed by capturing sequential scanning images using a
-Ab42 inside the cytoplasm of N2A cells. Scale bar, 20 lm. (D) The intensity of
ed from images captured in sequential scanning mode using a confocal microscope.
stical analysis of signiﬁcance by t-test: *P < 0.01.
Fig. 3. MEGF10-mediated Ab42 uptake in neuroblastoma cells is dependent on the lipid raft pathway. (A) N2A cells were incubated with 1 lg/ml FITC-Ab42 for 1 h at 37 C in
4-well chamber slides. After ﬁxing, the cells were stained with anti-EEA1 antibody (an early endosomal marker) and then analyzed by capturing sequential scanning images
using a confocal microscope to detect EEA1 (red) and Ab42 (green). Yellow indicates colocalization of EEA1 and Ab42 (merge of red and green). Scale bar, 10 lm. (B) N2A cells
were incubated with 1 lg/ml FITC-Ab42 for 1 h at 37 C in 4-well chamber slides. After ﬁxing, the cells were stained with Alexa Fluor 594-conjugated Cholera toxin B subunit
(a lipid raft marker) and then analyzed by capturing sequential scanning images using a confocal microscope to detect CTxB (red) and Ab42 (green). Yellow indicates
colocalization of CTxB and Ab42 (merge of red and green). Scale bar, 10 lm. (C) Colocalization of CTxB and Ab42 in MEGF10 siRNA-treated N2A cells. Scale bar, 10 lm. (D)
Quantiﬁcation of colocalization in Fig. 3A–C. The degree of colocalization between internalized Ab and EEA1 or CTxB was calculated as colocalization (%) = the pixel number of
co-localized Ab42 (yellow)/the pixel number of total internalized Ab42 (green + yellow). (E) MEGF10 siRNA- or control siRNA-treated N2A cells were pretreated with 5 mM
methyl-b-cyclodextrin (MbCD) for 30 min at 37 C and then incubated with 1 lg/ml FITC-conjugated Ab42 for 1 h at 37 C. The intensity of internalized FITC-Ab42 was
quantiﬁed from images captured in sequential scanning mode using a confocal microscope. Statistical analysis of signiﬁcance by t-test: *P < 0.01.
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in uptake of Ab peptides, HeLa cells were stably transfected with
full-length human MEGF10 cDNA containing an engineered
FLAG-tag at the C-terminus (HeLa/MEGF10). We used HeLa cells
for our experiments as they do not endogenously express MEGF10
[9]. HeLa/MEGF10 cells expressed a 125 kDa polypeptide that
corresponds to the molecular mass of human MEGF10 (Fig. 1A).
To investigate whether MEGF10 has the ability to uptake Ab42,
we analyzed Ab42 internalization in HeLa/MEGF10 and HeLa/mock
cells using confocal microscopy. HeLa/MEGF10 cells signiﬁcantly
internalized FITC-conjugated Ab42 (FITC-Ab42), whereas HeLa/
mock did not (Fig. 1B). The presence of FITC-Ab42 inside the cyto-
plasm of HeLa/MEGF10 cells was further conﬁrmed using confocal
microscopic z-series images (Fig. 1B). We also quantiﬁed internal-
ized FITC-Ab42 from images captured in sequential scanning mode
using a confocal microscope. Ab42 uptake in HeLa/MEGF10 cells
was increased by approximately ninefold compared with that of
HeLa/mock cells (Fig. 1C).
3.2. Knockdown of MEGF10 inhibits the uptake of Ab42
in neuroblastoma cells
The predominant expression of MEGF10 in the brain has been
previously reported [8,9]. We examined for the expression of
MEGF10 in murine cell lines of brain origin using quantitativereal-time PCR. N2A neuroblastoma cells showed strong expression
of MEGF10 (Fig. 2A). Because neuroblastoma cells are known to
mediate rapid uptake of amyloid-b peptides [17], we investigated
the role of MEGF10 in Ab42 uptake by knocking down endogenous
MEGF10 expression in N2A neuroblastoma cells. MEGF10 siRNA
used in this study showed the satisfactory silencing of MEGF10
at the protein levels (Fig. 2B). Treatment with MEGF10 siRNA sig-
niﬁcantly decreased uptake of FITC-Ab42 in N2A cells, whereas
treatment with control siRNA had no effect (Fig. 2C). Ab uptake de-
creased by approximately 40% in MEGF10 siRNA-treated N2A cells
compared to control siRNA-treated N2A cells (Fig. 2D). Taken to-
gether, our data clearly indicate that MEGF10 plays a role in the
uptake of Ab42.
3.3. Endocytosed Amyloid-b colocalizes with cholera B and is sensitive
to cholesterol loss
Clathrin and lipid raft-mediated endocytosis remain the two
best characterized mechanisms of ligand–receptor internalization
[18]. Clathrin-mediated endocytosis targets proteins to the early
endosomes (characterized by the presence of the protein EEA1),
where proteins are sorted for either recycling or trafﬁcking to late
endosomes and lysosomes [19]. The lipid raft pathway is another
important pathway, as lipid rafts are critically involved in amyloi-
dogenic processing of amyloid precursor protein (APP) [20]. To
Fig. 4. The NPxA and YxxØ motifs in MEGF10 are important for MEGF10-mediated Ab uptake. (A) Multiple sequence alignment of the cytoplasmic domains of MEGF10
orthologs was performed using T-Coffee multiple sequence alignment software (http://www.ebi.ac.uk/Tools/t-coffee/index.html). Completely conserved amino acid residues
are indicated by asterisks. (B) Schematic diagrams of the cytoplasmic regions of wild-type and mutant MEGF10. Amino acid positions of MEGF10 are designated by number.
(C) HeLa cells were transfected with wild-type or mutant MEGF10 expression vectors. At 48 h post-transfection, the cells were incubated with 1 lg/ml FITC-Ab42 for 1 h at
37 C. The intensity of internalized FITC-Ab42 in the cells was quantiﬁed from images captured in sequential scanning mode using a confocal microscope. The results are
expressed as the mean ± S.D. from three independent experiments. Statistical analysis of signiﬁcance by t-test: *P < 0.01.
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take, we analyzed whether internalized Ab co-localizes with
EEA1 (an early endosomal marker) or Cholera toxin B subunit (a li-
pid raft marker) in N2A cells. While only a minimal portion of
internalized Ab42 showed colocalization with EEA1 (Fig. 3A), the
majority of the internalized FITC-Ab appeared to co-localize with
Cholera toxin B subunit (CTxB) (Fig. 3B). When N2A cells were trea-
ted with MEGF10 siRNA, the internalized Ab42 that co-localized
with CTxB was reduced by 24%, compared with 62% in control
siRNA-treated cells (Fig. 3C and D). Methy-b-cyclodextrin selec-
tively inhibits caveolae/raft-dependent endocytosis, but not clath-
rin-dependent endocytosis [21]. To further conﬁrm whether
MEGF10-mediated Ab uptake is dependent to lipid raft-dependent
pathway, we examined the effect of cyclodextrin on Ab uptake inMEGF10 siRNA- or control siRNA-treated cells. Treatment with
cyclodextrin decreased Ab uptake by approximately 55% in control
siRNA-treated cells (Fig. 3E). Ab uptake is also slightly reduced by
treatment of cyclodextrin in MEGF10 siRNA-treated cells, but the
effect was not statistically signiﬁcant. These results suggest that
MEGF10-mediated Ab42 uptake is dependent on lipid raft-medi-
ated endocytosis.
3.4. Conserved NPxY and YxxØ motifs within MEGF10 are important
for Ab uptake
To verify which region is important for the signaling pathway of
MEGF10-mediated Ab endocytosis, we performed multiple
sequence alignment of the cytoplasmic domain from MEGF10
Fig. 5. MEGF10 expression in a double transgenic mouse model of Alzheimer’s disease (AD). Hippocampus (A) and cerebral cortex (B) regions from wild-type and AD animals
were stained with anti-MEGF10 antibody. MEGF10 is shown in red, and DAPI is shown in blue. Scale bar, 50 lm.
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bear homology to previously characterized endocytic signals,
including YxxØ (Y denotes tyrosine, x is a polar residue, and Ø re-
fers to amino acids with a large hydrophobic side chain) and NPxY
(N denotes asparagine, P is proline, x refers to any amino acid, and
Y is tyrosine) (Fig. 4A). In order to test whether the NPxY and YxxØ
motifs of the MEGF10 cytoplasmic region are involved in uptake of
Ab42, we generated two mutant MEGF10 expression vectors that
contain mutations in the NPxY or YxxØ motif of the MEGF10 cyto-
plasmic region, MEGF10-APxA (T927A, Y930A) and MEGF10-AxxA
(Y1061A, I1064A) (Fig. 4B). To assess the effect of the APxA or AxxA
mutation on MEGF10-mediated Ab uptake, HeLa cells were tran-
siently transfected with empty vector, wild-type MEGF10,
MEGF10-APxA, or MEGF10-AxxA cDNA, and their activity for the
uptake of Ab42 were examined using a confocal microscope.
Expression of wild-type MEGF10 signiﬁcantly enhanced the uptake
of FITC-Ab42 in HeLa cells. However, expression of MEGF10-APxA
and MEGF10-AxxA resulted in a lower increase in the uptake of
Ab42 than wild-type MEGF10 (Fig. 4C). Taken together, these re-
sults conﬁrm that the NPxY and YxxØ motifs in the cytoplasmic
domain of MEGF10 are crucial for cellular uptake of Ab42.
MEGF10 was identiﬁed as a gene encoding a protein that con-
tains multiple EGF-like domains from brain tissue [8]. Many cell
surface receptors contain multiple extracellular EGF-like repeats,
which are important for ligand–receptor interaction [22]. Several
receptors that participate in endocytosis and phagocytosis contain
EGF-like repeats, including LRP1 [9,23], Jedi-1 [24], and Eater [25].
Among these receptors, LRP1 is involved in several Abmetabolism,
including receptor-mediated endocytosis via association of Ab and
LRP ligands and Ab generation via APP processing [23,26]. Thisﬁnding suggests a possible role of MEGF10 in the uptake of Ab in
the brain. We present several lines of evidence supporting our
hypothesis that MEGF10 plays an important role in the internaliza-
tion of Ab42 in the brain. First, overexpression of MEGF10 mediates
the uptake of Ab42 in HeLa cells. Second, knockdown of endoge-
nous MEGF10 signiﬁcantly inhibits the uptake of Ab42 in N2A neu-
roblastoma cells. Third, confocal microscopic analysis showed that
MEGF10-mediated Ab uptake is mostly dependent on the lipid raft
pathway in N2A cells. Fourth, the NPxY and YxxØ motifs in the
MEGF10 cytoplasmic tail are important for uptake of Ab42. These
results show that MEGF10 functions as a receptor for Ab uptake.
Recently, it was shown that MEGF10 is associated with AP50
(Ap-2 mu subunit) in HEK293 cells expressing both MEGF10-EGFP
and AP50-DsRedMono [11], suggesting that trafﬁcking of MEGF10
is dependent on the clathrin complex pathway. However, our re-
sult in N2A neuroblastoma cells showed that the majority of inter-
nalized Ab42 co-localizes with lipid raft marker CTxB, but not EEA1
a marker of the clathrin-mediated pathway, consistent with recent
ﬁndings that Ab clearance in primary neurons is independent on
the clathrin pathway but partially dependent on dynamin and
the lipid raft-mediated pathway [27,28]. A recent study has pro-
posed a model in which free Ab and Ab bound to apoE and other
ligands enter the neurons via two different mechanisms, lipid raft
pathway and clathrin complex pathway [28]. Thus, this model may
be applied to MEGF10-mediated Ab internalization.
In addition to similarity with LRP1 in the extracellular domain,
MEGF10 also has the conserved cytoplasmic NPxY and YxxØ mo-
tifs. In the present study, our site-directed mutagenesis study re-
vealed that these motifs are important for MEGF10-mediated
uptake of Ab42. Although adaptor proteins for binding to the these
3942 T.D. Singh et al. / FEBS Letters 584 (2010) 3936–3942motifs remain to be established, several PTB domain-containing
proteins are involved in the metabolism of Ab via interactions with
NPxY motif, including nexin 17 [29,30], ARH [31], and FE65 [32].
Thus, it is possible that endocytic capacity of MEGF10 is regulated
by interactions between its NPxY motif and one of the PTB domain-
containing proteins. Furthermore, considering that LRP1 and
MEGF10 share many features [9,33], MEGF10 may have another
function in Ab metabolism such as APP processing or Ab export
from the brain.
The localization of MEGF10 within the brain is still not com-
pletely clear. In this study, our immunohistochemistry result
showed that MEGF10 expresses in hippocampus and cerebral cor-
tex region, in which the extracellular amyloid plaques are predom-
inantly formed (Fig. 5). Although we did not ﬁnd a signiﬁcant
difference in MEGF10 expression in wild-type and AD animals,
expression of MEGF10 was increased in an age-dependent manner
in both animals (Fig. 5). Thus, it is possible that MEGF10 is involved
in clearance of Ab which was formed in cerebral cortex and hippo-
campus regions at old age.
In summary, our results demonstrated that MEGF10 plays an
important role in the uptake of amyloid-b. Although the expression
level of MEGF10 in AD patients remains to be investigated, this
ﬁnding will help elucidate the molecular mechanism of amyloid-
b clearance in Alzheimer’s disease.
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